首页> 外文期刊>European Journal of Pharmacology: An International Journal >A proteasome inhibitor lessens the increased aortic endothelin-1 content in deoxycorticosterone acetate-salt hypertensive rats.
【24h】

A proteasome inhibitor lessens the increased aortic endothelin-1 content in deoxycorticosterone acetate-salt hypertensive rats.

机译:蛋白酶体抑制剂减少了醋酸脱氧皮质酮盐类高血压大鼠主动脉内皮素-1含量的增加。

获取原文
获取原文并翻译 | 示例
           

摘要

Deoxycorticosterone acetate (DOCA)-salt-treated rats developed marked hypertension after 4 weeks with an increase in aortic endothelin-1. Treatment of DOCA-salt hypertensive rats with a proteasome inhibitor, N-benzyloxycarbonyl-Ile-Glu(O-t-Bu)-Ala-leucinal, significantly reduced the elevation in systolic blood pressure and the effect was accompanied by a decrease in aortic endothelin- content. Thus, a proteasome-dependent proteolytic pathway appears to play an important role in the enhanced production of endothelin-1 in blood vessels and the consequent increase in blood pressure in this model of hypertension.
机译:醋酸脱氧肾上腺皮质激素(DOCA)盐治疗的大鼠在4周后出现明显的高血压,主动脉内皮素-1增加。用蛋白酶体抑制剂N-苄氧基羰基-Ile-Glu(Ot-Bu)-Ala-亮氨酸治疗DOCA-盐高血压大鼠,可显着降低收缩压升高,并且伴随主动脉内皮素含量降低。因此,在这种高血压模型中,蛋白酶体依赖性蛋白水解途径似乎在血管内皮素-1的产生增加以及由此引起的血压升高中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号